.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A12B_Potassium.A12BA51_PotassiumChlorideCombina.PotassiumChlorideCombina .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A12B_Potassium.A12BA51_PotassiumChlorideCombina.PotassiumChlorideCombina| name: | PotassiumChlorideCombinations |
| ATC code: | A12BA51 | route: | oral |
| n-compartments | 1 |
Potassium chloride in combination with other substances is used as an electrolyte replenisher to treat or prevent hypokalemia, a condition in which there are lower-than-normal levels of potassium in the blood. The drug is widely approved and currently used for this therapeutic purpose as a supplement, often in patients requiring potassium replacement due to diuretic therapy, vomiting, or other causes of potassium loss.
Estimated pharmacokinetic parameters for healthy adult individuals, as published data specifically for potassium chloride combination formulations with ATC A12BA51 is lacking.
Sattarzadeh, M, & Zlotkin, SH (1999). Iron is well absorbed by healthy adults after ingestion of double-fortified (iron and dextran-coated iodine) table salt and urinary iodine excretion is unaffected. The Journal of nutrition 129(1) 117–121. DOI:10.1093/jn/129.1.117 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9915886